Skip to main content
. 2023 Sep 14;23(2):362–376. doi: 10.17998/jlc.2023.08.03

Figure 5.

Figure 5.

Overall survival of elderly and non-elderly patients in advanced-stage hepatocellular carcinoma treated with transarterial and systemic therapy before (A, C) and after IPTW (B, D). IPTW, inverse probability of treatment weighting.